OpenURL Connection Search

Select item for more details and to access through your institution.

Neural Stem Cells as a Novel Platform for Tumor-Specific Delivery of Therapeutic Antibodies.
Published in:
PLoS ONE, 2009, v. 4, n. 12, p. 1, doi. 10.1371/journal.pone.0008314
By:
- Frank, Richard T.;
- Edmiston, Marissa;
- Kendall, Stephen E.;
- Najbauer, Joseph;
- Chia-Wei Cheung;
- Kassa, Thewodros;
- Metz, Marianne Z.;
- Kim, Seung U.;
- Glackin, Carlotta A.;
- Wu, Anna M.;
- Yazaki, Paul J.;
- Aboody, Karen S.
Publication type:
Article
A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance.
Published in:
PEDS: Protein Engineering, Design & Selection, 2013, v. 26, n. 3, p. 187, doi. 10.1093/protein/gzs096
By:
- Yazaki, Paul J.;
- Lee, Brian;
- Channappa, Divya;
- Cheung, Chia-Wei;
- Crow, Desiree;
- Chea, Junie;
- Poku, Erasmus;
- Li, Lin;
- Andersen, Jan Terje;
- Sandlie, Inger;
- Orcutt, Kelly Davis;
- Wittrup, K.Dane;
- Shively, John E.;
- Raubitschek, Andrew;
- Colcher, David
Publication type:
Article
Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting.
Published in:
PEDS: Protein Engineering, Design & Selection, 2004, v. 17, n. 4, p. 315, doi. 10.1093/protein/gzh040
By:
- Olafsen, Tove;
- Tan, Giselle J.;
- Cheung, Chia-wei;
- Yazaki, Paul J.;
- Park, Jinha M.;
- Shively, John E.;
- Williams, Lawrence E.;
- Raubitschek, Andrew A.;
- Press, Michael F.;
- Wu, Anna M.
Publication type:
Article
Covalent disulfide‐linked anti‐CEA diabody allows site‐specific conjugation and radiolabeling for tumor targeting applications.
Published in:
PEDS: Protein Engineering, Design & Selection, 2004, v. 17, n. 1, p. 21, doi. 10.1093/protein/gzh009
By:
- Tove Olafsen;
- Chia‐wei Cheung;
- Paul J. Yazaki;
- Lin Li;
- Gobalakrishnan Sundaresan;
- Sanjiv S. Gambhir;
- Mark A. Sherman;
- Lawrence E. Williams;
- John E. Shively;
- Andrew A. Raubitschek;
- Anna M. Wu
Publication type:
Article

Found: 4

Neural Stem Cells as a Novel Platform for Tumor-Specific Delivery of Therapeutic Antibodies.

A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance.

Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting.

Covalent disulfide‐linked anti‐CEA diabody allows site‐specific conjugation and radiolabeling for tumor targeting applications.